Walgreens Recalls Sodium Ascorbate Syringes Due to Sterility Concerns
Walgreens Infusion Services is recalling compounded Sodium Ascorbate (Vitamin C) syringes in Texas due to a lack of assurance of sterility.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II. According to the rubric, FDA Class II recalls are classified as Severe (Score 4), particularly when involving potential hospitalization or significant injury risks associated with sterility failures in injectable drugs.
Plain-English summary
Walgreens Infusion Services is recalling 30 syringes of Sodium Ascorbate (Vitamin C) in various concentrations (500 mg/1 mL, 1000 mg/2 mL, and 800 mg/1.6 mL). The product is compounded by Option Care 148 in San Antonio, Texas, and was distributed in Texas.
The recall was initiated because of a lack of assurance of sterility. The source text does not specify which lot numbers are affected, stating only that all lots within expiry are included. No specific dates of distribution or illness reports are provided in the source material.
Consumers who have these syringes should stop using them and contact their healthcare provider or the recalling firm for further instructions. The product is prescription-only.
The recalled product
- Product
- Sodium Ascorbate (Vitamin C) syringe, a) 500 mg/1 mL syringe, b)1000 mg/2 mL c) 800 mg/1.6 mL, Rx Only, Compounded by Option Care 148, San Antonio, TX 78232-5045
- Manufacturer
- Walgreens Infusion Services
- Category
- Drug — Compounded Injectable
- Affected units
- 30
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots within expiry.
Distribution
Distributed in 1 state:
Part of a larger recall action
This product is one of 33 recalled by Walgreens Infusion Services under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 33 products in this recall →Related recalls
Same manufacturer · Walgreens Infusion Services
See all →- SevereWalgreens Recalls IVIG Gamunex Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls Cefazolin Infusion Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Recalls 0.9% Sodium Chloride/MVI Injection Bags Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
- SevereWalgreens Infusion Services Recalls Dextrose and Sodium Chloride Injection Bags
FDA (Drugs) · 2016-01-06
- HighWalgreens Recalls Famotidine Injection Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-01-06
Same hazard · sterility failure
See all →- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereAvKare Carboxymethylcellulose Sodium Eye Drops Recalled for Sterility Concerns
FDA (Drugs) · 2026-09-30
- SevereROHTO DIGI-EYE Eye Drops Recalled Over Sterility Assurance Gap
FDA (Drugs) · 2026-07-29
- HighROHTO DRY-AID Eye Drops Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- SevereOne-Piece Introducer Tray kits recalled for sterility failure
FDA (Devices) · 2026-07-22
Similar recalls
- SevereWalgreens Recalls Folic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2015-01-28
- SevereSCA Pharmaceuticals Recalls Sodium Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2021-01-13
- SevereGuardian Pharmacy Recalls Ascorbic Acid Vials Due to Sterility Concerns
FDA (Drugs) · 2018-08-15
- SevereBaptist Health Recalls Ascorbic Acid Syringes Due to Sterility Concerns
FDA (Drugs) · 2016-06-08
- HighFDA Recalls Sodium Citrate Injectable Solution Due to Sterility Concerns
FDA (Drugs) · 2024-04-03
- SevereGuardian Pharmacy Recalls Fentanyl Citrate Syringes Due to Sterility Concerns
FDA (Drugs) · 2018-08-15